| 注册
首页|期刊导航|现代妇产科进展|妊娠期高血压疾病尿液差异蛋白质分析及其Perlecan含量变化

妊娠期高血压疾病尿液差异蛋白质分析及其Perlecan含量变化

郭红霞 王晨虹 冷灵芝 钟梅

现代妇产科进展2016,Vol.25Issue(4):253-256,4.
现代妇产科进展2016,Vol.25Issue(4):253-256,4.DOI:10.13283/j.cnki.xdfckjz.2016.04.004

妊娠期高血压疾病尿液差异蛋白质分析及其Perlecan含量变化

Urine protein analysis and clinical significance of perlecan in hypertensive disorders of pregnancy

郭红霞 1王晨虹 1冷灵芝 1钟梅2

作者信息

  • 1. 南方医科大学深圳医院妇产科,深圳 518028
  • 2. 南方医科大学南方医院妇产科,广州 510515
  • 折叠

摘要

Abstract

Objective:To evaluate the significance of the urine Perlecan in hyperten-sive disorders of pregnancy. Methods:Urine Perlecan concentrations were measured in 25 nor-mal pregnancies and 25 cases of gestational hypertension, mild preeclampsia and severe pre-eclampsia respectively. Correlation between urine Perlecan and mean arterial pressure and 24h urine protein was analyzed. Results:The concentration of urine Perlecan in gestational hyperten-sion was higher than that of normal pregnancies. However,the concentrations of urine Perlecan in mild preeclampsia and severe preeclampsia were significantly lower than that of normal preg-nancies,and there was higher concentration in mild preeclampsia when compared with severe preeclampsia. Correlation analyses demonstrated that significant negative correlations could be detected between urine Perlecan and 24h urine protein. Conclusions:Urine Perlecan can work as a good marker to reflect the state of hypertensive disorders in pregnancy.

关键词

尿液/Perlecan/妊娠期高血压疾病

Key words

Urine/Perlecan/Hypertensive disorders of pregnancy

分类

医药卫生

引用本文复制引用

郭红霞,王晨虹,冷灵芝,钟梅..妊娠期高血压疾病尿液差异蛋白质分析及其Perlecan含量变化[J].现代妇产科进展,2016,25(4):253-256,4.

基金项目

2014年深圳市卫生计生系统科研项目(No:201402067) (No:201402067)

现代妇产科进展

OA北大核心CSCDCSTPCD

1004-7379

访问量0
|
下载量0
段落导航相关论文